Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Xolair – Biological Therapy

Drug (Brand/Generic)

Xolair (omalizumab)

Company/Licensee

Tanox, Genentech and Novartis,

Therapy Class

Therapeutic MAb

Product Description

Recombinant humanised anti-IgE MAb

Current Indication

Allergic asthma in adults and adolescents

Market Sector

Respiratory

Development Status

Approved US and Europe
Expand

Go Top